| dc.contributor.author | Kirwan, CJ | en_US |
| dc.contributor.author | Jackson, L | en_US |
| dc.contributor.author | Prowle, JR | en_US |
| dc.date.accessioned | 2018-02-16T16:46:42Z | |
| dc.date.available | 2017-12-01 | en_US |
| dc.date.issued | 2018 | en_US |
| dc.date.submitted | 2018-01-07T22:29:20.018Z | |
| dc.identifier.issn | 0253-5068 | en_US |
| dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/32525 | |
| dc.format.extent | 129 - 130 | en_US |
| dc.language.iso | en | en_US |
| dc.relation.ispartof | BLOOD PURIFICATION | en_US |
| dc.rights | ‘This is the peer-reviewed but unedited manuscript version of the following article: Kirwan C, J, Jackson L, Prowle J, R, A Continuous Renal Replacement Therapy Protocol on the Updated Nikkiso Aquarius Platform Using Regional Citrate as First-Line Anticoagulation Significantly Improves Filter Life Span but the Position of the Vascular Access is Key. Blood Purif 2018;45:129-130. The final, published version is available at https://doi.org/10.1159/000485232.’ | |
| dc.title | A Continuous Renal Replacement Therapy Protocol on the Updated Nikkiso Aquarius Platform Using Regional Citrate as First-Line Anticoagulation Significantly Improves Filter Life Span but the Position of the Vascular Access is Key | en_US |
| dc.type | Article | |
| dc.rights.holder | © 2017 S. Karger AG, Basel. | |
| dc.identifier.doi | 10.1159/000485232 | en_US |
| pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000430844600020&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
| pubs.issue | 1-3 | en_US |
| pubs.notes | No embargo | en_US |
| pubs.publication-status | Published | en_US |
| pubs.volume | 45 | en_US |
